Promising Nanotechnology Stocks To Add to Your Watchlist – April 22nd

OSI Systems, NVE, and Biodexa Pharmaceuticals are the three Nanotechnology stocks to watch today, according to MarketBeat’s stock screener tool. Nanotechnology stocks are shares of companies that develop and commercialize technologies based on the manipulation of matter at the nanoscale, typically between 1 and 100 nanometers. These stocks represent firms involved in various sectors—such as healthcare, electronics, and materials science—that use nanotechnology to create innovative products, improve efficiencies, and drive breakthroughs in performance and sustainability. These companies had the highest dollar trading volume of any Nanotechnology stocks within the last several days.

OSI Systems (OSIS)

OSI Systems, Inc. designs and manufactures electronic systems and components. It operates in three segments: Security, Healthcare, and Optoelectronics and Manufacturing. The Security segment offers baggage and parcel inspection, cargo and vehicle inspection, hold baggage and people screening, radiation monitoring, explosive and narcotics trace detection systems, and optical inspection systems under the Rapiscan name.

OSIS stock traded up $1.42 during mid-day trading on Tuesday, hitting $189.46. 46,451 shares of the company were exchanged, compared to its average volume of 184,239. The business has a fifty day simple moving average of $193.87 and a 200-day simple moving average of $176.41. The firm has a market capitalization of $3.18 billion, a P/E ratio of 24.29, a PEG ratio of 1.81 and a beta of 1.19. OSI Systems has a 12-month low of $126.57 and a 12-month high of $220.00. The company has a quick ratio of 1.25, a current ratio of 1.88 and a debt-to-equity ratio of 0.56.

NVE (NVEC)

NVE Corporation develops and sells devices that use spintronics, a nanotechnology that relies on electron spin to acquire, store, and transmit information in the United States and internationally. The company manufactures spintronic products, including sensors and couplers for use in acquiring and transmitting data.

NVE stock traded up $0.63 during trading on Tuesday, hitting $57.26. The company had a trading volume of 5,765 shares, compared to its average volume of 22,211. The company’s 50 day simple moving average is $64.85 and its 200-day simple moving average is $73.32. NVE has a 1-year low of $51.50 and a 1-year high of $89.98. The stock has a market cap of $276.97 million, a price-to-earnings ratio of 18.47 and a beta of 1.05.

Biodexa Pharmaceuticals (BDRX)

Biodexa Pharmaceuticals Plc, a clinical stage biopharmaceutical company, focuses on developing a pipeline of products for the treatment of Type 1 diabetes and rare/orphan cancers of the brain. Its lead product candidate Tolimidone, a selective activator of the lyn kinase enzyme, currently under Phase II studies for the treatment of Type 1 diabetes.

Biodexa Pharmaceuticals stock traded up $0.02 during midday trading on Tuesday, reaching $1.40. 41,065 shares of the stock traded hands, compared to its average volume of 593,324. The company has a 50-day simple moving average of $2.34 and a two-hundred day simple moving average of $3.99. Biodexa Pharmaceuticals has a 12-month low of $1.14 and a 12-month high of $74.00.